Jupiter Neurosciences JUNS Cash Flow Statement (2023-2025)

NASDAQ JUNS
$5.17 +0.26 (+5.30%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -1.52M-0.62M-0.64M-0.61M-3.81M-1.40M-1.93M-4.02M-10.82M-2.87M
Share-based Compensation (Quarter) 0.21M0.10M0.53M-0.63M0.89M0.38M0.42M0.39M-0.41M
Cash from Operations (Quarter) -0.16M-0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.00M0.00M0.01M0.03M
Change in Working Capital
Change in Accured Expenses (Quarter) -0.04M0.02M0.02M0.08M-0.07M-0.01M0.18M-0.17M-0.02M
Other Working Capital Changes (Quarter) 0.14M0.02M0.04M-0.03M-0.04M
Financing Activities
Cash from Financing Activities (Quarter) 0.13M0.04M0.11M0.03M7.47M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.10M
Additional items
Change in Cash (Quarter) -0.03M-0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M3.07M
Free Cash Flow (Quarter) -0.16M-0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M
Net Cash Flow (Quarter) -0.03M-0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M-2.37M